Pulmonary Drug Delivery Devices: Global Market Report 2018-2024 - Lengthy Product Approvals and Issues Pertaining to Drug Stability are Hindering Growth - ResearchAndMarkets.com

DUBLIN--()--The "Pulmonary Drug Delivery Devices Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global pulmonary drug delivery devices market to grow with a CAGR of 6% over the forecast period of 2018-2024.

Pulmonary asthma and cystic fibrosis are the most common form of lungs disorders found among the global population. Thus increasing presence of large patient pool with respiratory disorder is expected to fuel the pulmonary drug delivery devices market. Besides this, increasing technological developments in the form of smart/digital inhalers, increasing number of smokers, and growth of the distribution network will also drive the demand for the pulmonary drug devices.

However lengthy product approvals and issues pertaining to the stability of the drugs are some of the hiccups hindering the market growth. Introduction of metered dose inhalers that delivers a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine can create huge growth opportunities in near future.

The global pulmonary drug delivery devices market has been dominated by the North America region over the historic period 2016 followed by Europe. Increasing number of patients affected with lungs disorder coupled with developed healthcare infrastructure are the key factors responsible for driving the growth of pulmonary drug delivery devices market in this region. Also rising geriatric population in the U.S to augment the growth of the market in this region.

Asia Pacific region is expected to be the fastest growing region on account of developing healthcare infrastructure , increased spending on healthcare in developing countries like India, China and other south East Asian countries.

Key Topics Covered

1. Preface

2. Executive Summary

3. Global Pulmonary Drug Delivery Devices Market Overview

4. Global Pulmonary Drug Delivery Devices Market by Product Type

5. Global Pulmonary Drug Delivery Devices Market by Application

6. Global Pulmonary Drug Delivery Devices Market by Distribution Channel

7. Global Pulmonary Drug Delivery Devices Market by Region 2018-2024

8. Companies Covered

  • Teva Pharmaceutical Industries Ltd.
  • AstraZeneca Plc
  • GlaxoSmithkline Plc
  • Boehringer Ingelheim GmbH
  • Merck & Co. Inc.
  • Novartis AG
  • Omron Corporation
  • Sunovion Pharmaceuticals Inc.
  • GF Health Products, Inc.
  • 3M Healthcare

For more information about this report visit https://www.researchandmarkets.com/research/37b276/pulmonary_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery